WHC is still in active development. Read this to understand our approach.
depiction of HPFVBGJFAYZEBE-UHFFFAOYSA-N.svg
isomerdesign

3-Oxoandrost-4-en-17...

Check on isomerdesign

drugmap

Testosterone cypiona...

Check on drugmap

Data

InChI: InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3

Synonyms: Testosterone cyclopentanepropionate, Sustanon, Testosterona, M0XW1UBI14, Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17b)-, Oreton, Testrone, Perandren, Testobase, Testopropon, AndroGel, Testostosterone, Virormone, Depo-Testosterone, Testoviron T, Testosteroid, Testosterone cyclopentylpropionate,3-Oxoandrost-4-en-17β-yl 3-cyclopentylpropanoate, Testandrone, trans-Testosterone, Testosterone 17beta-cypionate, Andro-Cyp, Orquisteron, Testosterone cypionate [USP], Homosteron, Virosterone, Andropatch, 58-20-8, Relibra, DEPO, Testiculosterone, Sustanone, Cristerona T, Neotestis, Depovirin, LibiGel, Depo-Testadiol, Jectatest, CHEBI:9463, Malerone, Testim, Testoviron, Pertestis, Cristerone T, Mertestate, Testoderm, Testoviron Schering, TESTOSTERONE CYPIONATE,Testodrin prolongatum,(8R,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl 3-cyclopentylpropanoate, Testosterone 17beta-cyclopentylpropionate, Synandrol F, T-Ionate-P.A, Primotest, Depotest, Testosteron, Homosterone, Androderm, Testryl, Andrusol, Teslen, Testosteronum, depAndro 100, Testogel, NSC 9157, Primoteston, 58-22-0,(17β)-3-Oxoandrost-4-en-17-yl 3-cyclopentylpropanoate, Dep-Test, Malogen CYP, UNII-M0XW1UBI14, depAndro 200, testosterone, Andronaq, Durandro, Androlin


Estimated data

Solubility: -6.704 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 80.0% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.